首页|宁波市北仑区肺结核患者耐药现状及危险因素分析

宁波市北仑区肺结核患者耐药现状及危险因素分析

扫码查看
目的 明确宁波市北仑区肺结核患者的耐药现状,并对耐药肺结核尤其是耐多药肺结核进行危险因素分析.方法 回顾性选取2017年1月至2021年12月宁波市北仑区人民医院诊治的707例肺结核患者为研究对象,分析肺结核患者耐药情况.比较不同性别、年龄、户籍、职业、症状、有无结核病史、有无糖尿病史、有无高血压病史患者耐药肺结核发生率,采用多因素logistic回归分析耐多药肺结核发生的危险因素.结果 707例患者均培养出结核分枝杆菌,对一线抗结核药物敏感患者576例,耐药患者131例,总耐药率为18.53%(131/707),单药耐药率、多耐药率和耐多药率分别为10.61%(75/707)、3.25%(23/707)和4.67%(33/707).单因素分析结果显示,有结核病史、有糖尿病史、距上次抗结核治疗时间>2年患者耐多药率分别高于无结核病史、无糖尿病史、距上次抗结核治疗时间≤2年患者,差异均有统计学意义(均P<0.05);距上次抗结核治疗时间>2年患者耐利福平率高于距上次抗结核治疗时间≤2年患者(P<0.05);有高血压病史患者耐异烟肼率高于无高血压病史患者(P<0.05);从事商业服务的患者单耐链霉素或乙胺丁醇率高于其他职业患者(P<0.05).多因素logistic回归分析显示有结核病史是肺结核患者发生耐多药的独立危险因素(P<0.05).结论 北仑区2017—2021年肺结核患者总耐药率及耐多药率偏低,防治工作取得了一定成效,但仍不能松懈,提高初治成功率是关键.
Analysis on drug-resistance status and risk factors in pulmonary tuberculosis patients in Beilun District,Ningbo City
Objective To clarify the drug-resistance status of tuberculosis patients in Beilun District,Ningbo,and to analyze the risk factors associated with drug-resistant tuberculosis,particularly multidrug-resistant tuberculosis. Methods A retrospective study was conducted involving 707 tuberculosis patients diagnosed and treated at Beilun District People's Hospital from January 2017 to December 2021. The drug-resistance status of these patients was analyzed. The occurrence rates of drug-resistant tuberculosis were compared among different groups based on sex,age,household registration,occupation,symptoms,tuberculosis history,diabetes history,and hypertension history. Multivariate logistic regression analysis was employed to identify the risk factors for multidrug-resistant tuberculosis. Results Mycobacterium tuberculosis was cultured from all 707 patients. Among them,576 were sensitive to first-line anti-tuberculosis drugs,while 131 were resistant,resulting in an overall drug resistance rate of 18.53%(131/707). The rates of mono-resistance,poly-resistance,and multidrug-resistance were 10.61%(75/707),3.25%(23/707),and 4.67%(33/707),respectively. The results of univariate analysis showed that the rates of multidrug-resistant in patients with a history of tuberculosis,a history of diabetes,and those whose time since the last anti-tuberculosis treatment was>2 years were respectively higher than those in patients without a history of tuberculosis,without a history of diabetes,and those whose time since the last anti-tuberculosis treatment was ≤ 2 years (all P<0.05). The rate of rifampicin resistance in patients whose time since the last anti-tuberculosis treatment was>2 years was higher than that in patients whose time since the last anti-tuberculosis treatment was ≤ 2 years (P<0.05). The rate of isoniazid resistance in patients with a history of hypertension was higher than that in patients without a history of hypertension (P<0.05). The rate of single resistance to streptomycin or ethambutol among patients engaged in commercial services was higher than that among patients of other occupations (P<0.05). Multivariate logistic regression analysis identified a history of tuberculosis as an independent risk factor for developing multidrug-resistance in tuberculosis patients (P<0.05). Conclusion The overall drug-resistance rate and multidrug-resistance rate of pulmonary tuberculosis patients in Beilun District from 2017 to 2021 are relatively low,indicating positive results in prevention and control of the disease. However,vigilance must still be maintained,and improving the success rate of initial treatment remains crucial.

Pulmonary tuberculosisDrug-resistanceMultidrug-resistanceRisk factor

钟珊珊、王芳、樊思桐、俞雯文、金敬波、陈佳佳

展开 >

310003 杭州,浙江大学医学院附属第一医院感染科

宁波市北仑区人民医院(浙江大学医学院附属第一医院北仑分院)感染科

肺结核 耐药 耐多药 危险因素

2024

浙江医学
浙江省医学会

浙江医学

CSTPCD
影响因子:0.428
ISSN:1006-2785
年,卷(期):2024.46(22)